Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avotermin for scar improvement in head and neck naevi excision
NCT00656227Phase 2Unknown
- Sponsor
- Renovo
- Start
- Apr 2004
- Primary completion
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avotermin in cicatrix, sponsored by Renovo. Status: unknown.
02
Drugs
avotermin
03
Conditions
cicatrix
Beyond the preview
Go deeper on NCT00656227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656227.